LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Lista de Ações・Pulse Biosciences Inc
Search

Pulse Biosciences Inc

Fechado

SetorSaúde

25.06 -3.09

Comprar

Atualização de preço 10 de jun. de 2026, 19:58 UTC

ComprarVender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

24.71

Máximo

25.82

Indicadores-chave

By Trading Economics

Rendimento

-1.1M

-19M

Vendas

137K

401K

EPS

-0.241

Margem de lucro

-4,633.666

Funcionários

116

EBITDA

-1.4M

-19M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+20.29% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

179M

1.7B

Abertura anterior

28.15

Fecho anterior

25.06

Sentimento de Notícias

By Acuity

17%

83%

30 / 344 Ranking em Healthcare

Pulse Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de jun. de 2026, 23:36 UTC

Ganhos

Correction to Oracle Reports Higher 4Q Profit Article

DJ

Ler

10 de jun. de 2026, 23:19 UTC

Ações em Alta

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

DJ

Ler

10 de jun. de 2026, 23:09 UTC

Grandes Movimentos do Mercado

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

DJ

Ler

10 de jun. de 2026, 23:04 UTC

Ganhos

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

DJ

Ler

10 de jun. de 2026, 20:44 UTC

Grandes Movimentos do Mercado

Caterpillar Raises Quarterly Dividend 8%

DJ

Ler

10 de jun. de 2026, 23:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott: Northern Star Should Take No Options Off The Table

DJ

Ler

10 de jun. de 2026, 23:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

DJ

Ler

10 de jun. de 2026, 23:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

DJ

Ler

10 de jun. de 2026, 23:47 UTC

Conversa de Mercado

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

DJ

Ler

10 de jun. de 2026, 23:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

DJ

Ler

10 de jun. de 2026, 23:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

DJ

Ler

10 de jun. de 2026, 23:38 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 23:38 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 23:38 UTC

Conversa de Mercado

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

DJ

Ler

10 de jun. de 2026, 23:32 UTC

Conversa de Mercado

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

DJ

Ler

10 de jun. de 2026, 23:20 UTC

Conversa de Mercado

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

DJ

Ler

10 de jun. de 2026, 22:05 UTC

Conversa de Mercado

Correction to Bank of Canada Stays on Hold Market Talk

DJ

Ler

10 de jun. de 2026, 21:57 UTC

Ganhos

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

DJ

Ler

10 de jun. de 2026, 21:52 UTC

Ganhos

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

DJ

Ler

10 de jun. de 2026, 21:35 UTC

Ganhos

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

DJ

Ler

10 de jun. de 2026, 21:22 UTC

Ganhos

Oracle Stock Slides on Increased Capital Spending -- WSJ

DJ

Ler

10 de jun. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 20:39 UTC

Conversa de Mercado
Ganhos

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

DJ

Ler

10 de jun. de 2026, 20:34 UTC

Ganhos

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

DJ

Ler

10 de jun. de 2026, 20:33 UTC

Ganhos

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

DJ

Ler

10 de jun. de 2026, 20:33 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

DJ

Ler

10 de jun. de 2026, 20:33 UTC

Conversa de Mercado
Ganhos

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

DJ

Ler

Comparação entre Pares

Variação de preço

Pulse Biosciences Inc Previsão

Preço-alvo

By TipRanks

20.29% parte superior

Previsão para 12 meses

Média 31 USD  20.29%

Máximo 32 USD

Mínimo 30 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Pulse Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Com base em 2 analistas que deram avaliações de ações para Pulse Biosciences Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

30 / 344 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Outras ações do setor

LLY

Eli Lilly and Co.

1,136.41

↓-0.5%

JNJ

Johnson and Johnson

238.85

↑ +0.91%

ABBV

AbbVie Inc

225.29

↑ +0.05%

UNH

UnitedHealth Group Inc

407.06

↓-1.28%

MRK

Merck & Co Inc.

119

↓-0.38%
help-icon Live chat